Dr Reddy's launches Nitroglycerin tablets in the US

A medicine that opens blood vessels to improve blood flow, used to treat patients complaining of chest pain among other symptoms

Dr Reddy's Laboratories Limited on Monday announced that it has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat in the US market on August 26, following the approval from the US Food and Drug Administration (USFDA).

The Nitrostat had US sales of approximately $108 million for the most recent twelve months ending in March 2016, the company said citing the IMS data.

Nitroglycerin is a vasodilator, a medicine that opens blood vessels to improve blood flow and is used to treat patients complaining of chest pain among other symptoms.

The company scrip was up Rs 9.50 at Rs 3,049.75 in the afternoon trade on Bombay Stock Exchange on Tuesday.